Parabilis Medicines, Inc. (PBLS)
Nasdaq: PBLS · Pharmaceutical Preparations · filing with the SEC since 2015
Who runs Parabilis Medicines, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Mammen Mathai
President & CEO. First filing Jun 2026, latest Jun 9, 2026, 0 filings in all.
Officers reporting now
6
of 19 people with a filing in the last fifteen months
Directors reporting now
13
19 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Mammen Mathai | President & CEO | Jun 2026 | Jun 9, 2026 | none |
| Kotarakos Thomas Rodolpho | Chief Financial Officer | Jun 2026 | Jun 9, 2026 | none |
| Benzaghou Mohammed Fawzi | Chief Medical Officer | Jun 2026 | Jun 9, 2026 | none |
| Ho Helen Huei-In | Exhibit 24 - Power of Attorney; Title: Chief Business and Strategy Officer | Jun 2026 | Jun 9, 2026 | none |
| Mhatre Rohin | Exhibit 24 - Power of Attorney; Title: Chief Technical Operations Officer | Jun 2026 | Jun 9, 2026 | none |
| Jurgensen Teresa | General Counsel | Jun 2026 | Jun 9, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Tendler Craig | director | Aug 2026 | Aug 25, 2026 | none |
| Kolchinsky Peter | director | Jun 2026 | Jul 22, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Jun 2026 | Jul 22, 2026 | none |
| Ra Capital Management, L.P. | director | Jun 2026 | Jul 22, 2026 | none |
| Ra Capital Nexus Fund III, L.P. | director | Jun 2026 | Jul 22, 2026 | none |
| Shah Rajeev M. | director | Jun 2026 | Jul 22, 2026 | none |
| Sebulsky Alan | director | Jun 2026 | Jun 16, 2026 | none |
| Borisy Alexis | director | Jun 2026 | Jun 15, 2026 | none |
| Fitzgerald Edward M | director | Jun 2026 | Jun 15, 2026 | none |
| Klausner Richard | director | Jun 2026 | Jun 11, 2026 | none |
| Simson Jake | director | Jun 2026 | Jun 11, 2026 | none |
| Weber Barbara | director | Jun 2026 | Jun 11, 2026 | none |
| Yeshwant Krishna | director | Jun 2026 | Jun 11, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Levy Guy | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Capital Group, LLC | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Capital Management, L.P. | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Capital Master Fund, L.P. | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Capital, LLC | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Gp, LLC | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Pe Gp III, LLC | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Private Equity Fund III, L.P. | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Soleus Private Equity Gp III, LLC | 10% owner | Jun 2026 | Jun 29, 2026 | none |
| Deerfield Healthcare Innovations Fund, L.P. | 10% owner | Jun 2026 | Jun 11, 2026 | none |
| Deerfield Management Company, L.P. | 10% owner | Jun 2026 | Jun 11, 2026 | none |
| Deerfield Mgmt Hif, L.P. | 10% owner | Jun 2026 | Jun 11, 2026 | none |
| Deerfield Mgmt III, L.P. | 10% owner | Jun 2026 | Jun 11, 2026 | none |
| Deerfield Private Design Fund III, L.P. | 10% owner | Jun 2026 | Jun 11, 2026 | none |
| Flynn James E | 10% owner | Jun 2026 | Jun 11, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.